- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.09. | EXTRAWELL PHAR (00858): FURTHER EXTENSION OF LONG STOP DATE IN RESPECT OF PROPOSED FOURTH AMENDMENTS TO THE TERMS AND CONDITIONS OF THE BONDS | 3 | HKEx | ||
| 11.09. | EXTRAWELL PHAR (00858): FURTHER DELAY IN DESPATCH OF CIRCULAR IN RESPECT OF THE MAJOR TRANSACTION IN RELATION TO THE PROPOSED FOURTH AMENDMENTS TO THE ... | 1 | HKEx | ||
| 28.08. | EXTRAWELL PHAR (00858): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | - | HKEx | ||
| 28.08. | EXTRAWELL PHAR (00858): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 28 AUGUST 2026 AND RETIREMENT OF DIRECTOR | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2026, CIRCULAR DATED 31 ... | 4 | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF ANNUAL REPORT 2026, CIRCULAR DATED 31 ... | 2 | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M. | - | HKEx | ||
| EXTRAWELL PHARMACEUTICAL Aktie jetzt für 0€ handeln | |||||
| 30.07. | EXTRAWELL PHAR (00858): PROPOSALS FOR GENERAL MANDATES TO ISSUE NEW SHARES AND BUY BACK SHARES, RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL ... | - | HKEx | ||
| 30.07. | EXTRAWELL PHAR (00858): ANNUAL REPORT 2026 | 1 | HKEx | ||
| 30.06. | EXTRAWELL PHAR (00858): ANNUAL RESULTS FOR THE YEAR ENDED 31 MARCH 2026 | 1 | HKEx | ||
| 23.06. | EXTRAWELL PHAR (00858): PROFIT WARNING | - | HKEx | ||
| 16.06. | EXTRAWELL PHAR (00858): DATE OF BOARD MEETING | 2 | HKEx | ||
| 29.05. | EXTRAWELL PHAR (00858): (1) FURTHER EXTENSION OF LONG STOP DATE IN RESPECT OF PROPOSED FOURTH AMENDMENTS TO THE TERMS AND CONDITIONS OF THE BONDS (2) ... | - | HKEx | ||
| 14.04. | EXTRAWELL PHAR (00858): NEXT DAY DISCLOSURE RETURN | 3 | HKEx |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS | 40,640 | +5,26 % | Genentech, Ionis Reveal Positive Interim Data From Phase III Sefaxersen Study In IgA Nephropathy | SOUTH SAN FRANCISCO (dpa-AFX) - Genentech, affiliated to Swiss drug major Roche Holding AG (RHHBY, RO.SW, ROG.SW), and partner Ionis Pharmaceuticals, Inc. (IONS) announced Wednesday positive... ► Artikel lesen | |
| CSPC PHARMA | 1,016 | -3,90 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - DATA FROM PHASE I CLINICAL STUDY OF SYS6002 AS MONOTHERAPY FOR THE TREATMENT OF ADVANCED CERVICAL CANCER ... | ||
| SELLAS LIFE SCIENCES | 10,400 | +3,48 % | SELLAS Life Sciences Group Inc mit PAUKENSCHLAG: Folgt jetzt der nächste Kursrutsch? - Unbedingt noch vor Börsenschluss lesen! | ||
| MADRIGAL PHARMACEUTICALS | 425,00 | -0,02 % | Madrigal: Rezdiffra zeigt in MASH-Studie konsistente Wirksamkeit über genetische Varianten hinweg | ||
| ACADIA PHARMACEUTICALS | 17,620 | +0,92 % | RBC Capital bestätigt Einstufung für Acadia Pharmaceuticals nach Patent-Entwicklungen | ||
| CATALYST PHARMACEUTICALS | 27,300 | +2,63 % | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | The Italian pharma company grows its presence in the U.S. market and strengthens its global leadership in Brain Health and Rare DiseasesCompletion of the transaction gives Angelini Pharma ownership... ► Artikel lesen | |
| OPUS GENETICS | 4,200 | +5,53 % | Could an FDA Nod for MR-141 Give Viatris (VTRS) and Opus Genetics (IRD) a Presbyopia Payoff? | ||
| SAVARA | 4,439 | +2,95 % | Citizens reiterates Savara stock rating on Molbreevi launch outlook | ||
| ELITE PHARMACEUTICALS | - | - | Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2027 Ended June 30, 2026 and Provides Conference Call Information | Northvale, New Jersey--(Newsfile Corp. - August 13, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products... ► Artikel lesen | |
| GALECTIN THERAPEUTICS | 3,200 | +0,63 % | Galectin Therapeutics Inc.: Galectin Therapeutics to Present at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting 2026 | ||
| BIODEXA PHARMACEUTICALS | 0,461 | -11,97 % | Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer | ||
| NEURIZON THERAPEUTICS | 0,048 | 0,00 % | NEURIZON THERAPEUTICS LIMITED: Updated Investor Presentation and Webinar Reminder | ||
| CIPHER PHARMACEUTICALS | 8,150 | 0,00 % | Cipher Pharmaceuticals Announces the Appointment of Rajiv De Silva to its Board of Directors | ||
| ACURA PHARMACEUTICALS | - | - | ACURA PHARMACEUTICALS, INC - 8-K, Current Report | ||
| VASO | - | - | Vaso Corporation Announces Financial Results for Second Quarter of 2026 | PLAINVIEW, N.Y., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Vaso Corporation ("Vaso") (OTCQX: VASO), a leading MedTech company with a business portfolio in professional sales services and proprietary non-invasive... ► Artikel lesen |
Das Unternehmen EXTRAWELL PHARMACEUTICAL HOLDINGS LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EXTRAWELL PHARMACEUTICAL HOLDINGS LTD finden Sie auf Wallstreet Online.